Tech Company Financing Transactions
Reverie Labs Funding Round
On 2/5/2021, Reverie Labs raised $25 million in Series A funding from Ridgeback Capital, First Round Capital and Neo.
Transaction Overview
Company Name
Announced On
2/5/2021
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series A
Investors
Proceeds Purpose
Reverie will use the proceeds to advance its internal and partnered drug discovery programs towards the clinic, further develop its innovative computational discovery platform, and grow its world-class, cross-disciplinary team of scientists and engineers.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
678 Massachusetts Ave.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Reverie Labs (YC W18) optimizes potential medicines using machine learning. Using recently-developed machine learning techniques, Reverie Labs has developed best-in-class structure-based predictive models for potency and ADME/PK properties of small molecules.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonah Kallenbach
Chief Technical Officer
Ankit Gupta
Browse more venture capital transactions:
Prev: 2/5/2021: Elucidata venture capital transaction
Next: 2/5/2021: Latitude venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs